Geena Malhotra
Overview
Explore the profile of Geena Malhotra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Usmani O, Molimard M, Gaur V, Gogtay J, Singh G, Malhotra G, et al.
Clin Pharmacokinet
. 2017 Mar;
56(10):1139-1154.
PMID: 28290122
In recent years, pathways for the development and approval of bioequivalent inhaled products have been established for regulated markets, including the European Union (EU), and a number of orally inhaled...
2.
Chachad S, Gole M, Malhotra G, Naidu R
Clin Ther
. 2014 May;
36(6):967-73.
PMID: 24844853
Background: Fenofibrate is a serum lipid-lowering agent used as an adjunct to diet in patients with hypercholesterolemia and hypertriglyceridemia. The new fenofibrate tablet formulation was developed as a pharmaceutical equivalent...
3.
Gogtay J, Malhotra G
Curr Opin HIV AIDS
. 2013 Oct;
8(6):550-5.
PMID: 24100875
Purpose Of Review: In the last decade, there has been marked progress in the treatment of HIV/AIDS. Today, nearly 10 million people are receiving ART. Yet, there are several opportunities...
4.
Chachad S, Purandare S, Malhotra G, Naidu R
Cancer Chemother Pharmacol
. 2012 Oct;
71(2):287-92.
PMID: 23090620
Purpose: The objective of this study was to compare the pharmacokinetics and safety of two tablet formulations containing 500 mg of capecitabine (CAS number 154361-50-9) in patients with colon, colorectal...
5.
Chachad S, Lulla A, Malhotra G, Purandare S
Arzneimittelforschung
. 2009 Dec;
59(10):537-40.
PMID: 19998583
The study was designed to compare the rate and extent of absorption of a fixed dose combination tablet of lamivudine (CAS 134678-17-4) and stavudine (CAS 3056-17-5) with the concurrent administration...
6.
Chachad S, Gogtay J, Malhotra G, Purandare S
J Pharm Sci
. 2009 Sep;
99(2):572-3.
PMID: 19718766
No abstract available.
7.
Chachad S, Lulla A, Malhotra G, Purandare S
Arzneimittelforschung
. 2009 Jun;
59(5):263-8.
PMID: 19537528
The study was designed to compare the rate and extent of absorption of two fixed dose combination tablet formulations of lopinavir (CAS 192725-17-0) and ritonavir (CAS 155213-67-5). This bioequivalence study...
8.
Bhavna , Ahmad F, Mittal G, Jain G, Malhotra G, Khar R, et al.
Eur J Pharm Biopharm
. 2008 Nov;
71(2):282-91.
PMID: 18984050
Nanoparticle DPI is known to have deeper lung penetration but its clinical utility as a potentially better treatment option needs to be evaluated in the light of higher expected mucociliary...
9.
Ali R, Jain G, Iqbal Z, Talegaonkar S, Pandit P, Sule S, et al.
Nanomedicine
. 2008 Sep;
5(1):55-63.
PMID: 18799362
The aim of the work was to develop, characterize, and carry out a clinical trial with nano-atropine sulfate (nano-AS) dry powder inhaler (DPI), because this route may offer several advantages...
10.
Narang V, Lulla A, Malhotra G, Purandare S
Arzneimittelforschung
. 2005 Nov;
55(10):598-603.
PMID: 16294506
Nevirapine (CAS 129618-40-2), a non-nucleoside reverse transcriptase inhibitor, has been effectively used for treatment of HIV-infected patients. A randomized, two-way, crossover study was conducted in 24 fasting, healthy, Indian male...